ZD 7288
Alternative Names: ICID 7288Latest Information Update: 06 Sep 2000
Price :
$50 *
At a glance
- Originator AstraZeneca
- Class Antiarrhythmics; Heart failure therapies; Ischaemic heart disorder therapies; Pyrimidines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Heart failure
Most Recent Events
- 06 Sep 2000 Discontinued-II for Arrhythmias in United Kingdom (Unknown route)
- 06 Sep 2000 Discontinued-Unspecified phase in Heart failure in United Kingdom (Unknown route)
- 21 Dec 1999 No-Development-Reported for Arrhythmias in United Kingdom (Unknown route)